There has been a lot happening in the proposed deal between Sanofi-Aventis and Genzyme and in the latest turn of events, Sanofi, the French drug company has said that it will be extending its tender t

The way the shareholders of French drugmaker, Sanofi Aventis, have shown their dissent towards its bid for US biotech firm, Genzyme; there is no doubt that it is presently in a very critical situation

It has been found by the FDA that some patients who have taken Sanofi-Aventis' (SNY) Multaq heart disease drug have suffered from some or the other kind of liver disease.

An unfriendly offer for Genzyme Corp. is created by the French drugmaker, Sanofi-Aventis SA, extended the time limit for the U. S. biotechnology company's shareholders to caring their stock to Jan.

Henri Termeer has put in much of his specialized life constructing Cambridge- foundation Genzyme into a worldwide biotech source of power, and it might all enter in to an abrupt conclusion if French drug colossal Sanofi-Aventis do well in its attempts to obtain the company.

French drug producer Sanofi-Aventis SA expressed that on Wednesday its investigational blood vessel medicine NV1FGF botched to convene its objective in a tardy - phase clinical assessment.

The news drive shares of U. S. biotechnology corporation Vical Inc that authorize the drug to Sanofi, to a 52-week low on Wednesday.

The Company board member has unanimously decided to drop the $18.5 billion all-cash proposal made by French drugmaker Sanofi-Aventis, Genzyme Corp. announced on Monday.

The decision has been backed with claims that the offer would undervalue the Company.

Rotavirus vaccines made by GlaxoSmithKline and Merck and Sanofi Aventis, have the potential to protect the lives of million of poor children suffering from diarrhea.